Le Lézard
Classified in: Health, Science and technology
Subject: AWD

Evidence Prime Wins Main Prize for the Best Technological Solution in "The Eagle of Innovation" Competition organized by the editors of "Rzeczpospolita" daily in Poland

Evidence Prime, a leading provider of innovative technology solutions, is proud to announce that it has been awarded the main prize for Best Technological Solution in the prestigious Eagle of Innovation competition held in Poland. This recognition highlights Evidence Prime's commitment to delivering cutting-edge solutions that revolutionize the life sciences industry and drive forward technological advancements.

GDARISK, Poland, May 27, 2023 /PRNewswire-PRWeb/ -- The price has been awarded to Evidence Prime for its flagship product, Laser AI. This advanced solution, based on natural language processing (NLP) and artificial intelligence (AI), helps life sciences organizations around the world make data-driven decisions, streamline processes, and enhance operational efficiency. Laser AI has significantly improved the way organizations manage and analyze vast amounts of data, supporting the creation of so-called Living Systematic Reviews (LSR) - systematic reviews updated on an ongoing basis.

"We are thrilled to receive the main prize for Best Technological Solution in the Eagle of Innovation competition," said Pawel Kunstman, President of Evidence Prime. "In 2018, we committed all our efforts to the development of Natural Language Processing technologies capable of handling the overwhelming volume of evidence that needs to be analyzed to make the right healthcare decisions. This award is a testament to the hard work and dedication of our talented team, which made achieving this goal possible. We are grateful for this honour and remain committed to delivering cutting-edge solutions that drive transformative change in the life sciences industry."

Evidence Prime received the main prize in the category of the Best Technological Solution during the Eagle of Innovation award ceremony on the 24th of May, 2023, in Gda?sk, Poland. The event gathered influential leaders, industry experts, and key stakeholders to celebrate the achievements of innovative companies and their contributions to the European technological landscape.

About Evidence Prime:

Evidence Prime is a global leader in the market of evidence-based healthcare guidelines and systematic review authoring, focusing on innovative, AI-driven tools for this market. Its flagship product, Laser AI, is a revolutionary system for automating the development of systematic reviews in healthcare. Already in use by leading US and German governmental institutions as well as major corporations, Laser AI streamlines the review process, allowing for more efficient and accurate analysis of healthcare data. With its commitment to data security, Evidence Prime stands out as the most secure Software-as-a-Service (SaaS) provider in its domain, bringing the safest and most effective solutions to accelerate research efforts. For more information about Evidence Prime, its groundbreaking products, and its commitment to security, visit https://laser.ai and https://evidenceprime.com.

Media Contact

Klaudia Kepa, Evidence Prime, 48 12 881 40 72, press@evidenceprime.com


SOURCE Evidence Prime

These press releases may also interest you

at 22:15
The "Peripheral Vascular Stents Market Size, Share & Trends Analysis Report, 2023 - 2030" has been added to  ResearchAndMarkets.com's offering. With peripheral vascular diseases (PVDs) on the rise, the healthcare sector leans heavily on innovative...

at 21:23
Note: All times local Northern Saskatchewan, Saskatchewan 11:00 a.m.  The Prime Minister will mark the third National Day for Truth and Reconciliation by participating in an awareness walk and attending local community events with community members,...

at 20:30
Vitality Products Inc. (the "Company" or "Vitality") is pleased to report its financial results for the second quarter ended July 31, 2023....

at 20:15
The "Vascular Grafts - Global Strategic Business Report" report has been added to  ResearchAndMarkets.com's offering. The global Vascular Grafts market is poised for robust growth, with an estimated value of US$3.3 billion in 2022 and a projected...

at 20:13
Global health company The Cigna Group announced it has fully resolved pending legal matters related to certain past Medicare Advantage risk adjustment practices. Under agreements with the federal government, The Cigna Group will pay approximately...

at 19:45
The "Image Guided Surgery Devices - Global Strategic Business Report" report has been added to  ResearchAndMarkets.com's offering. The global market for Image Guided Surgery Devices, estimated at US$4.6 million in 2022, is on a growth trajectory,...

News published on and distributed by: